1. Home
  2. LION vs ARQT Comparison

LION vs ARQT Comparison

Compare LION & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$11.74

Market Cap

4.1B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.86

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
ARQT
Founded
1997
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
LION
ARQT
Price
$11.74
$24.86
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$11.89
$34.00
AVG Volume (30 Days)
2.3M
1.7M
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
N/A
0.03
Revenue
$2,631,800,000.00
$376,072,000.00
Revenue This Year
N/A
$34.85
Revenue Next Year
$22.98
$29.39
P/E Ratio
N/A
$826.00
Revenue Growth
N/A
91.34
52 Week Low
$5.88
$15.10
52 Week High
$16.70
$31.77

Technical Indicators

Market Signals
Indicator
LION
ARQT
Relative Strength Index (RSI) 31.84 43.01
Support Level $9.11 $24.91
Resistance Level $12.58 $25.47
Average True Range (ATR) 0.49 1.17
MACD -0.02 -0.18
Stochastic Oscillator 12.94 13.16

Price Performance

Historical Comparison
LION
ARQT

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: